Pliant Therapeutics is a USD 1.8 bn US based clinical-stage bio-pharmaceutical company developing new treatments for idiopathic pulmonary fibrosis (IPF). Pliant reminds us of Belgian biotech Galapagos ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results